In the BioHarmony Drug Report Database

"Preview" Icon

Buspirone

Buspar (buspirone) is a small molecule pharmaceutical. Buspirone was first approved as Buspar on 1986-09-29. It is used to treat anxiety disorders, depressive disorder, and intellectual disability in the USA. The pharmaceutical is active against 5-hydroxytryptamine receptor 1A. In addition, it is known to target 5-hydroxytryptamine receptor 7.

 

Trade Name

 

Buspar
 

Common Name

 

buspirone
 

ChEMBL ID

 

CHEMBL49
 

Indication

 

anxiety disorders, depressive disorder, intellectual disability
 

Drug Class

 

Anxiolytics (buspirone type)

Image (chem structure or protein)

Buspirone structure rendering